Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus - Insights into its mechanisms of action

British Journal of Pharmacology

Volumn 166, Issue 8, 2012, Pages 2209-2211

  Stefanska, B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

curcumin; hepatic fibrosis; hepatic stellate cells; RAGE; type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CURCUMIN; GLUTATHIONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ATHEROSCLEROSIS; CELL ACTIVATION; CURCUMA LONGA; DISEASE ASSOCIATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; IN VITRO STUDY; INFLAMMATION; LIVER FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAGE GENE; REVIEW; STELLATE CELL; SYNTHESIS;

ANIMALS; CURCUMIN; HEPATIC STELLATE CELLS; MALE; PPAR GAMMA; RECEPTORS, IMMUNOLOGIC;

EID: 84864486921     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01959.x     Document Type: Review

References (19)

1. Aggarwal BB, (2010). Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30: 173-199.
2. Basnet P, Skalko-Basnet N, (2011). Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16: 4567-4598.
3. Belkacemi A, Doggui S, Dao L, Ramassamy C, (2011). Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev Mol Med 13: e34.
4. Bermudez V, Finol F, Parra N, Parra M, Perez A, Penaranda L, et al,. (2010). PPAR-gamma agonists and their role in type 2 diabetes mellitus management. Am J Ther 17: 274-283.
5. Chen A, Zheng S, (2008). Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br J Pharmacol 153: 557-567. (Pubitemid 351199009)
6. Fujiki K, Kano F, Shiota K, Murata M, (2009). Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 7: 38.
7. Jha AK, Nikbakht M, Parashar G, Shrivastava A, Capalash N, Kaur J, (2010). Reversal of hypermethylation and reactivation of the RARbeta2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha) 56: 195-200.
8. Kang HC, Nan JX, Park PH, Kim JY, Lee SH, Woo SW, et al,. (2002). Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro. J Pharm Pharmacol 54: 119-126. (Pubitemid 34116231)
9. Kang Q, Chen A, (2009). Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol 157: 1354-1367.
10. Lin J, Tang Y, Kang Q, Feng Y, Chen A, (2012). Curcumin inhibits advanced glycation end-products (AGEs)-induced gene expression of receptor for AGEs (RAGE) in hepatic stellate cells in vitro by elevating PPARIγ activity and attenuating oxidative stress. Br J Pharmacol 166: 2212-2227.
11. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al,. (2009). Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19: 706-709.
12. Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, et al,. (2010). Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome. PLoS ONE 5: e14229.
13. Ramasamy R, Yan SF, Schmidt AM, (2009). RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J Leukoc Biol 86: 505-512.
14. Rogers N, Stephenson M, Kitching A, Horowitz J, Coates P, (2011). Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen presenting cells. Br J Pharmacol 166: 194-209.
15. Rungseesantivanon S, Thenchaisri N, Ruangvejvorachai P, Patumraj S, (2010). Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med 10: 57.
16. Siu D, (2010). A new way of targeting to treat coronary artery disease. J Cardiovasc Med (Hagerstown) 11: 1-6.
17. Tang Y, Chen A, (2010). Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase. Br J Pharmacol 161: 1137-1149.
18. World Health Organization, Media Centre (2011). Fact sheet No. 312, August 2011. Retrieved from http://www.who.int/mediacentre/factsheets/fs312/en/ index.html.
19. Xu J, Fu Y, Chen A, (2003). Activation of peroxisome proliferator- activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285: G20-G30. (Pubitemid 36736384)